Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY END-USERS • Overview • Comparison by end-users • Pharmaceutical and biotechnology industry • Chemical and petrochemical industry • Others • Market opportunity by end-user PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas • EMEA • APAC • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Increase in use of hyphenated technology • Growing investments in biomedical industry • Increasing demand for instruments for personalized medicine • Increasing demand for portable instruments PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Agilent Technologies • Bruker • JEOL • Merck Group • Thermo Fisher Scientific • Other prominent vendors PART 15: APPENDIX • List of abbreviations Exhibit 01: Parent market Exhibit 02: Global molecular spectrometer market: Segments Exhibit 03: Market characteristics Exhibit 04: Global NMR spectrometer market: Segments Exhibit 05: Market definition: Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global NMR spectrometer market 2017-2022 ($ millions) Exhibit 09: Global NMR spectrometer market: Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition: Five forces 2017 Exhibit 18: Market condition: Five forces 2022 Exhibit 19: Global NMR spectrometer market: Segmentation by end-users 2017-2022 (% share) Exhibit 20: Comparison by end-users Exhibit 21: Global NMR spectrometer market by pharmaceutical and biotechnology industry 2017-2022 ($ millions) Exhibit 22: Global NMR spectrometer market by pharmaceutical and biotechnology industry: Year-over-year growth 2018-2022 (%) Exhibit 23: Global NMR spectrometer market by chemical and petrochemical industry 2017-2022 ($ millions) Exhibit 24: Global NMR spectrometer market by chemical and petrochemical industry: Year-over-year growth 2018-2022 (%) Exhibit 25: Global NMR spectrometer market by others 2017-2022 ($ millions) Exhibit 26: Global NMR spectrometer market by others: Year-over-year growth 2018-2022 (%) Exhibit 27: Market opportunity by end-users Exhibit 28: Customer landscape Exhibit 29: Global NMR spectrometer market: Segmentation by geography 2017-2022 (% share) Exhibit 30: Regional comparison Exhibit 31: NMR spectrometer market in Americas 2017-2022 ($ millions) Exhibit 32: NMR spectrometer market in Americas: Year-over-year growth 2018-2022 (%) Exhibit 33: Top-three countries in Americas Exhibit 34: NMR spectrometer market in EMEA 2017-2022 ($ millions) Exhibit 35: NMR spectrometer market in EMEA: Year-over-year growth 2018-2022 (%) Exhibit 36: Top-three countries in EMEA Exhibit 37: NMR spectrometer market in APAC 2017-2022 ($ millions) Exhibit 38: NMR spectrometer market in APAC: Year-over-year growth 2018-2022 (%) Exhibit 39: Top-three countries in APAC Exhibit 40: Market opportunity Exhibit 41: Pharmaceutical R&D spending in US and Europe Exhibit 42: Region-wise growth of R&D spending in biomedical industry 2010-2015 Exhibit 43: Vendor landscape Exhibit 44: Landscape disruption Exhibit 45: Vendors covered Exhibit 46: Vendor classification Exhibit 47: Market positioning of vendors Exhibit 48: Agilent Technologies: Overview Exhibit 49: Agilent Technologies: Business segments Exhibit 50: Agilent Technologies: Organizational developments Exhibit 51: Agilent Technologies: Geographic focus Exhibit 52: Agilent Technologies: Segment focus Exhibit 53: Agilent Technologies: Key offerings Exhibit 54: Bruker: Overview Exhibit 55: Bruker: Business segments Exhibit 56: Bruker: Organizational developments Exhibit 57: Bruker: Geographic focus Exhibit 58: Bruker: Segment focus Exhibit 59: Bruker: Key offerings Exhibit 60: JEOL: Overview Exhibit 61: JEOL: Business segments Exhibit 62: JEOL: Organizational developments Exhibit 63: JEOL: Geographic focus Exhibit 64: JEOL: Segment focus Exhibit 65: JEOL: Key offerings Exhibit 66: Merck Group: Overview Exhibit 67: Merck Group: Business segments Exhibit 68: Merck Group: Organizational developments Exhibit 69: Merck Group: Geographic focus Exhibit 70: Merck Group: Segment focus Exhibit 71: Merck Group: Key offerings Exhibit 72: Thermo Fisher Scientific: Overview Exhibit 73: Thermo Fisher Scientific: Business segments Exhibit 74: Thermo Fisher Scientific: Organizational developments Exhibit 75: Thermo Fisher Scientific: Geographic focus Exhibit 76: Thermo Fisher Scientific: Segment focus Exhibit 77: Thermo Fisher Scientific: Key offerings

Agilent Technologies, Bruker, JEOL, Merck Group, and Thermo Fisher Scientific